Keyword Connections

osimertinib

Journals

2

1 chemical society reviews

2 cancer

Research Groups

0

No Research Group Connected

Bibliographies

9

1 Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).

2 Recent advances in circularly polarized electroluminescence based on organic light-emitting diodes.

3 The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties.

4 Transition-metal-catalyzed reactions involving reductive elimination between dative ligands and covalent ligands.

5 small-cell carcinoma transformation of pulmonary adenocarcinoma after osimertinib treatment: a case report

6 first-line treatment in egfr mutant non-small cell lung cancer: is there a best option?

7 Development of an LC-MS/MS-based method for quantitation of osimertinib in human plasma and cerebrospinal fluid.

8 severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non‐small cell lung cancer harboring egfr mutation

9 Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion.